Yüklüyor......
Selecting Patients at Risk of Developing DKA on Gliflozins
Background: Since the introduction of gliflozins less than a decade ago we have witnessed how these medications are changing our approach to treating patients with type 2 diabetes mellitus. While recognizing tremendous benefits from these medication we are aware of potentially fatal risks. We presen...
Kaydedildi:
| Yayımlandı: | J Endocr Soc |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089501/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.811 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|